UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia

American Journal of Hematology

Volumn 83, Issue 10, 2008, Pages 800-803

  Carpenter, Shannon L ^a,d,e   Lieff, Susan ^b   Howard, Thad A ^c   Eggleston, Barry ^b   Ware, Russell E ^c  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b RHO INC   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d CHRISTUS Santa Rosa Hospital   (United States)

^e Division of Pediatric Hematology/Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; GLUCURONOSYLTRANSFERASE 1A1;

ALLELE; ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD; DISEASE PREDISPOSITION; GALLBLADDER DISEASE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SCREENING; GENOTYPE; HUMAN; HYPERBILIRUBINEMIA; MAJOR CLINICAL STUDY; PATIENT IDENTIFICATION; PHENOTYPIC VARIATION; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SICKLE CELL ANEMIA; TANDEM REPEAT; WILD TYPE;

ALLELES; ANEMIA, SICKLE CELL; BILIRUBIN; CHILD; COHORT STUDIES; GALLBLADDER DISEASES; GLUCURONOSYLTRANSFERASE; HUMANS; HYPERBILIRUBINEMIA; LOGISTIC MODELS; LONGITUDINAL STUDIES; MULTICENTER STUDIES AS TOPIC; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; VARIATION (GENETICS);

EID: 53549124698     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21264     Document Type: Article

References (24)

1. West MS, Wethers D, Smith J, Steinberg M. Laboratory profile of sickle cell disease: A cross-sectional analysis. J Clin Epidemiol 1992;45:893-909.
2. Duvaldestin P, Mahu JL, Metreau JM, et al. Possible role of a defect in hepatic bilirubin glucuronidation in the initiation of cholesterol gallstones. Gut 1980;21:650-655.
3. Del Giudice EM, Perrotta S, Nobili B, et al. Coinheritance of Gilbert Syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis. Blood 1999;94:2259-2262.
4. Perotta S, del Giudice EM, Carbone R, et al. Gilbert's syndrome accounts for the phenotypic variability of congenital dyserythropoietic anemia type II (CDA-II) J Peds 2000;136:556-559.
5. Lachman BS, Lazerson J, Starshak RJ, et al. The prevalence of cholelithiasis in sickle cell disease as diagnosed by ultrasound and cholecystography. Pediatrics 1979;64:601-603.
6. Sarnalk S, Slovis TL, Corbett DP, et al. Incidence of cholelithiasis in sickle cell anemia using the ultrasonic gray-scale technique. J Pediatr 1980;96:1005-1008.
7. Ware R, Filston HC, Schultz WH, Kinney TR. Elective cholecystectomy in young patients with sickle hemoglobinopathies. Ann Surg 1988;208:17-22.
8. Haberkern CM, Neumayr LD, Orringer EP, et al. Cholecystectomy in sickle cell anemia patients: Perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Blood 1997;89:1533-1542.
9. Werlin SL, Scott JP. Is biliary sludge a stone-in-waiting? J Pediatr 1996; 129: 321-322.
10. Kadakol A, Ghosh SS, Sappal BS, et al. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: Correlation of genotype to phenotype. Hum Mutat 2000;16:297-306.
11. Bosma PJ, Chowdhury JR, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyl-transferase 1 in Gilbert's syndrome. N Engl J Med 1995;333:1171-1175.
12. Monaghan G, Ryan M, Seddon R, et al. Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert syndrome. Lancet 1996;347:578-581.
13. Sampietro M, Lupica L, Perrero L, et al. The expression of uridine diphosphate glucuronosyl-transferase gene is a major determinant of bilirubin level in heterozygous β-thalassaemia and in glucose-6-phosphate dehydrogenase deficiency. Br J Haematol 1997;99:437-439.
14. Galanello R, Piras S, Barella S, et al. Cholelithiasis and Gilbert's syndrome in homozygous β-thalassemia. Br J Haematol 2001;115:926-928.
15. Beutler E, Gelbart T, Démina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A) promoter: A balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 1998;95:8170-8174.
16. Passon RG, Howard TA, Zimmerman SA, et al. The influence of bilirubin UDP-glucuronosyl-transferase 1A (UGT1A) promoter polymorphisms on serum bilirubin levels and cholelithiasis in pediatric patients with sickle cell anemia. Am J Pediatr Hematol Oncol 2001;23:448-451.
17. Heeney MM, Howard TA, Zimmerman SA, Ware RE. UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia. J Lab Clin Med 2003;141:279-282.
18. Haverfield EV, McKenzie CA, Forrester T, et al. UGT1A1 variation and gallstone formation in sickle cell disease. Blood 2005;105:968-972.
19. Chaar V, Keclard L, Diara JP, et al. Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia. Haematologica 2005;90:188-193.
20. Vasavda N, Menzel S, Kondaveeti S, et al. The linear effects of a-thalasaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease. Br J Haematol 2007;138:263-270.
21. Chaar V, Kéclard L, Etienne-Julan M, et al. UGT1A1 Polymorphism outweighs the modest effect of deletional (-3.7 Kb) α-thalassemia on cholelithogenesis in sickle cell anemia. Am J Hematol 2006;81:377-379.
22. Kato GJ, McGowan V, Machado RF, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism leg ulceration, pulmonary hypertension and death in patients with sickle cell disease. Blood 2006;107:2279-2285.
23. Gaston M, Rosse WF. The cooperative study of sickle cell disease: Review of study design and objectives. Am J Pediatr Hematol Oncol 1982;4:197-201.
24. Gaston M, Smith J, Gallagher D, et al. Recruitment in the Cooperative Study of Sickle Cell Disease (CSSCD). Control Clin Trials 1987;8:131S-140S.